Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

MELOXICAM TABLETS

Awarded
SPE2DP26F9472Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2DP26F9472 to DMS Pharmaceutical Group Inc. on September 2, 2026, for the procurement of Meloxicam tablets. This delivery order was issued under the broader base administrative contract SPE2DX25D9900, which originated from solicitation SPE2DX-24-R-0001 and carries a total award value of 19,999,999 dollars. The specific order for Meloxicam tablets, identified by NSN 6505015413243, consists of 45 units at a unit price of 90.00 dollars. The procurement is categorized under NAICS code 424210 and is managed by the DLA Troop Support Medical Supply Chain FSB. Terms for this delivery order include FOB destination with destination inspection and acceptance, with shipment specifically designated for the USS Illinois (SSN-786). This action is part of a larger contractual framework that replaces previous agreement SPE2DX25D9383 under the primary base contract SPE2DX25D9000.

General Info

DLA awarded DMS Pharmaceutical Group 4,050 dollars for Meloxicam tablets for USS Illinois.

Contract Value

$90

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DP-26-F-9472 Order for Supplies or Services

PDF, Low prioritycontract-document
Low

SPE2DX-25-D-9900 Award/Order Form

PDF, Low priorityaward
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9472 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $90.00 Award Date: 09-02-2026 Delivery order under: SPE2DX25D9900 Line items: - MELOXICAM TABLETS (NSN/Part 6505015413243, PR 7018169384)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is soliciting quotes for a one-time purchase of antibiotics to be stockpiled for emergency preparedness against Category A agents, including anthrax, plague, and tularemia. The procurement requires 30,000 tablets of Ciprofloxacin (500mg/dose) and 200,000 tablets of Doxycycline Hyclate (100mg/dose). All products must be FDA approved and comply with CDC and California Department of Public Health standards. Strict adherence to cold-chain requirements, temperature-controlled transport using monitoring devices, and full lot-level traceability is mandatory. Deliveries must be made to the Pasadena Public Health Department within four business days of an order, with the entire purchase completed by the end of the fiscal year on June 30, 2027. Bids must be submitted electronically via the City's eProcurement Portal by 3:00 PM PT on October 28, 2026. Responsive proposals must include pricing for all items, a Unique Entity Identifier (UEI) from SAM.gov, and completed forms regarding equal employment opportunity, relevant experience, and lobbying certifications. The contract is subject to FEMA supplemental terms and conditions, including prohibitions on covered telecommunications equipment and compliance with the Davis-Bacon Act for prevailing wages. Selected vendors must provide a Pasadena Business License and proof of insurance prior to award. Payment is issued on a Net 30 basis via the city's Vendor Invoice Portal.
Public Health Department

POSTED

about 19 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-27-T-0142
Solicitation SPE2DP-27-T-0142 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon-flavored electrolyte oral rehydration powder. The item is an FDA-regulated over-the-counter product provided in packages containing 100 packets, with each 21 gram packet formulated to provide 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when dissolved in 16.9 fluid ounces of solution. The requirement consists of multiple line items, including a primary request for 2 packages, with a required delivery date of October 23, 2026. Delivery is set as FOB Destination to the USS TUCSON SSN 770, with a delivery window of 20 days after receipt of order. The contract mandates strict adherence to the DLA Master List of Technical and Quality Requirements, specifically RA001 and RP001 for packaging. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The product has a non-extendable shelf life of 24 months. Packaging must be commercial and sealed to prevent damage, with specific requirements for hazardous materials per FED-STD-313 and ASTM D3951. Administrative requirements include electronic invoicing via Wide Area WorkFlow and compliance with the Buy American Act and DFARS cybersecurity standards. The solicitation utilizes the HUBZone price evaluation preference and requires all quotes to be submitted through the DLA Internet Bid Board System.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
International
Pralidoxime
Solicitation # W6369-26-A033/B
The Department of National Defence, through the Strategic Medical Countermeasures Program, is soliciting offers for the procurement of Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. The contract includes an initial requirement for 450 treatment courses to be delivered by March 31, 2027, with optional requirements for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. A treatment course is defined as 1 gram per day for seven days. The award will be granted to the compliant offer with the lowest evaluated price, based on Delivered at Place terms for the Central Medical Equipment Depot in Petawawa, Ontario. Technical requirements mandate that the product be manufactured according to current Good Manufacturing Practices and hold a Health Canada issued Notice of Compliance or appropriate authorization. The medication must have a minimum shelf-life of 36 months from the date of manufacture and be delivered in a temperature-controlled environment, specifically maintained between 2 to 8 degrees Celsius, with continuous electronic monitoring and a Certificate of Conformity provided upon delivery. All packaging and drug inserts must be available in English or French. There are no security requirements associated with this procurement, and the solicitation is open to Canadian suppliers and those of applicable trading partners.
Department of National Defence

POSTED

3 days ago

DEADLINE

in 19 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS